1. Home
  2. AVT vs RGEN Comparison

AVT vs RGEN Comparison

Compare AVT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avnet Inc.

AVT

Avnet Inc.

HOLD

Current Price

$88.84

Market Cap

7.1B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$141.01

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVT
RGEN
Founded
1921
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.6B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
AVT
RGEN
Price
$88.84
$141.01
Analyst Decision
Hold
Buy
Analyst Count
3
12
Target Price
$59.33
$167.67
AVG Volume (30 Days)
917.6K
1.2M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
1.72%
N/A
EPS Growth
N/A
286.96
EPS
2.49
0.24
Revenue
$22,200,754,000.00
$141,236,000.00
Revenue This Year
$14.39
$14.30
Revenue Next Year
$5.44
$14.52
P/E Ratio
$35.08
$597.90
Revenue Growth
N/A
35.10
52 Week Low
$44.25
$100.99
52 Week High
$95.26
$175.77

Technical Indicators

Market Signals
Indicator
AVT
RGEN
Relative Strength Index (RSI) 52.75 52.24
Support Level $81.80 $139.40
Resistance Level $88.16 $147.14
Average True Range (ATR) 2.69 7.36
MACD -0.02 -0.68
Stochastic Oscillator 63.17 48.56

Price Performance

Historical Comparison
AVT
RGEN

About AVT Avnet Inc.

Avnet Inc is an electronic component technology distributor and solutions provider. It serves customers from startups and mid-sized businesses to enterprise-level original equipment manufacturers (OEMs), electronic manufacturing services (EMS) providers, and original design manufacturers (ODMs). The group operates in the Electronic Components segment and supports high and medium-volume customers to markets, sells, and distributes electronic components, and the Farnell segment supports lower-volume customers that need electronic components quickly to develop, prototype, and test their products. Its geographic regions are the Americas, EMEA, and Asia.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: